Pay in 4 interest-free payments of $5.79 Learn more
Ships within 48 hours · Estimated delivery Oct 29 - Nov 3
Qu G, Bahr-Davidson J, Prado J et al
Separating the two compounds would require a lab and chemistry expertise
Phase 2 Metabolic Benefits Beyond weight loss, retatrutide improved cardiometabolic markers: Blood pressure: Systolic BP decreased 7.4 mmHg (12mg dose) Triglycerides: Reduced 27% from baseline Fasting glucose: Decreased 13.8 mg/dL HbA1c: Reduced 0.4% (in participants without diabetes) TRIUMPH-4: First Phase 3 Results (December 2025) TRIUMPH-4 was the first Phase 3 trial to report
Favorable 97% Mixed 3% Unfavorable overall 0% Most reported benefits Benefits users selected when logging a favorable or mixed check-in
Improved Skin Texture: Smoother, softer, and more refined skin
US$ 23.15
US$ 28.73
US$ 28.27
